Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2024-04-30 2024-04-30
Drug Identification Number 02516160 02516160
Brand name HYDRALAZINE HYDROCHLORIDE INJECTION, USP HYDRALAZINE HYDROCHLORIDE INJECTION, USP
Common or Proper name HYDRALAZINE HYDROCHLORIDE INJECTION, USP HYDRALAZINE HYDROCHLORIDE INJECTION, USP
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients HYDRALAZINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1ML 1ML
ATC code C02DB C02DB
ATC description ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2024-03-04 2024-03-04
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments HYDRALAZINE HYDROCHLORIDE INJECTION, USP is now available under Eugia Pharma label (DIN 02537699). HYDRALAZINE HYDROCHLORIDE INJECTION, USP is now available under Eugia Pharma label (DIN 02537699).
Health Canada comments